ClinicalTrials.Veeva

Menu

MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education

C

California State University, Northridge

Status

Not yet enrolling

Conditions

Alcohol Use
Prescription Opioid Misuse
Cannabis Use
Nicotine Use
Illicit Drug Use

Treatments

Behavioral: MATAspire Web-app

Study type

Interventional

Funder types

Other

Identifiers

NCT06553196
H79SP083737

Details and patient eligibility

About

The MATAspire intervention is a web-app designed to promote substance misuse prevention education and bolster protective coping skills whereby students complete six weekly interactive modules using a smart device or computer. Each module is approximately 15-20 minutes long and focuses on select substances and coping strategies: (i) adaptive coping strategies, (ii) alcohol, (iii) cannabis, (iv) nicotine, (v) prescription drugs and opioids, (vi) final module. The modules are based on key theoretical constructs, behavior change strategies, and practical module components: attitudes (knowledge), perceived susceptibility (risk perceptions), and subjective norms (normative re-education). The intervention will be evaluated via a time series design using a sample of (~1000 students) randomly assigned to either the intervention or the control conditions at a public institution in Southern California.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Current Cal State Northridge (CSUN) matriculated students with active CSUN email
  • Age 18 and older

Exclusion criteria

  • Not currently a CSUN student
  • CSUN students under the age of 18 years
  • Have previously participated in this study
  • Identified as having an alcohol or substance use disorder (AUD or SUD) as determined by the brief Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 screener

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,000 participants in 2 patient groups

Prevention group
Experimental group
Description:
Web-app with 6 weekly coping \& substance modules
Treatment:
Behavioral: MATAspire Web-app
Control Group
No Intervention group
Description:
No access to web-app

Trial contacts and locations

0

Loading...

Central trial contact

Linn Dahlman, MPhil; Bethany Rainisch, PhD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems